Natriuretic peptides in unstable coronary artery disease

European Heart Journal
Tomas JernbergLars Wallentin

Abstract

Patients with unstable coronary artery disease (CAD), i.e., unstable angina or non-ST-elevation myocardial infarction, vary widely in clinical presentation, prognosis and response to treatment. To select appropriate therapy, early risk stratification has become increasingly important. This review focuses on the emerging role of natriuretic peptides in the early assessment of patients with unstable CAD. We conclude that levels of brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) are strongly associated to mortality and the risk of future congestive heart failure, and carry important prognostic information independent from previously known risk factors in unstable CAD. There are some data indicating that these markers can also be helpful in the selection of appropriate therapy in these patients but further studies are needed. Before a routine use of BNP or NT-proBNP in unstable CAD can be recommended, the cost-effectiveness of adding these new markers to the currently routine markers and their impact on selection of treatment needs further evaluation.

Citations

Sep 8, 2010·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Sebastian SzardienChristian W Hamm
Jun 11, 2005·Journal of Cardiac Failure·Kiang-Teck J YeoTimothy Brough
Mar 24, 2007·Nature Clinical Practice. Cardiovascular Medicine·Michael J LipinskiGeorge W Vetrovec
Oct 20, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Francesca Di SerioNicola Pansini
Apr 28, 2011·Heart Failure Reviews·Aldo ClericoMichele Emdin
May 9, 2012·Clinical and Experimental Hypertension : CHE·Ying LiuXiaofeng Wang
Apr 26, 2014·The American Journal of the Medical Sciences·Sheng-Yong DongQiang Zeng
Mar 1, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Dina MelkiTomas Jernberg
Jun 23, 2009·Seminars in Arthritis and Rheumatism·Theodoros DimitroulasLoucas Settas
Jul 25, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Konstantinos KazanisAmalia Dionyssiou-Asteriou
Jun 19, 2007·Annales de cardiologie et d'angéiologie·P SchianoJ Monségu
Dec 22, 2006·European Journal of Clinical Investigation·V J Karthikeyan, G Y H Lip
Jul 9, 2008·Preventive Cardiology·Kellan E AshleyStephen J Nicholls
Mar 21, 2007·Journal of the American College of Cardiology·Gene KwanRobert L Fitzgerald
Jan 24, 2007·Journal of the American College of Cardiology·UNKNOWN Heart Protection Study Collaborative GroupRory Collins
Sep 26, 2007·Respiratory Medicine·Ralf-Harto HübnerBurkhard Bewig
Jan 21, 2015·Cardiology in the Young·Massimiliano CantinottiAldo Clerico
Aug 25, 2016·Journal of Clinical Anesthesia·Nikolaos PatelisEleni Arnaoutoglou
Oct 28, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Dipak KotechaDavid Eccleston
May 21, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ioannis A ParaskevaidisDimitrios Th Kremastinos
Mar 17, 2005·European Heart Journal·Sigmund SilberUNKNOWN Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
Dec 24, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Aldo ClericoMichele Emdin
Apr 5, 2019·BMC Medicine·Dipak KotechaUNKNOWN Alternative Risk Markers in Coronary Artery Disease (ARM-CAD) Study

❮ Previous
Next ❯